Phase II study of oxaliplatin in poor-prognosis non-small cell lung cancer (NSCLC). ATTIT. Association pour le Traitement des Tumeurs Intra Thoraciques.

Source:http://linkedlifedata.com/resource/pubmed/id/9849465

Download in:

View as

General Info

PMID
9849465